Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, and other life science companies. It sells four main product categories: filtration and fluid management is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia-Pacific contribute about 44%, 37%, and 19% of revenue, respectively.

What symbol and exchange does Repligen shares trade?

Repligen trades on the NASDAQ stock market under the symbol RGEN.

What is Repligen stock price doing today?

As of October 16, 2026, RGEN stock price declined to $175.42 with 1,158,545 million shares trading.

What is Repligen's Beta?

RGEN has a beta of 1.27, meaning it tends to be more sensitive to market movements. RGEN has a correlation of 0.11 to the broad based SPY ETF.

How much is Repligen worth?

RGEN has a market cap of $11.14 billion. This is considered a Large Cap stock.

How much money does Repligen make?

Last quarter Repligen reported $204 million in Revenue and $.54 earnings per share. This beat revenue expectation by $3 million and exceeded earnings estimates by $.09.

What is the highest and lowest price Repligen traded in the last 3 year period?

In the last 3 years, RGEN traded as high as $211.13 and as low as $100.99.

What are the top ETFs holding Repligen?

The top ETF exchange traded funds that RGEN belongs to (by Net Assets): IJH, VTI, VB, VBK, VXF.

Is Repligen (RGEN) a good investment?

RGEN has underperformed the market in the last year with a price return of +13.5% while the SPY ETF gained +16.7%. However, in the short term, RGEN had mixed performance relative to the market. It has outperformed in the last 3 months, returning +18.1% vs +1.9% return in SPY. But in the last 2 weeks, RGEN shares have been beat by the market, returning -3.5% compared to an SPY return of -0.8%.

What are the support and resistance levels for Repligen (RGEN)?

RGEN support price is $177.58 and resistance is $190.76 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that RGEN shares will trade within this expected range on the day.